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a b s t r a c t
An 81-year-old man was scheduled for an elective implantable cardioverter deﬁbrillator (ICD) generator
exchange because of battery depletion. The Atlas™+ DR ICD (St. Jude Medical, Sylmar, CA) had been
implanted in February 2007 for primary prevention. The ICD lead (Riata 1570, St. Jude Medical, Sylmar,
CA) had been positioned via the left cephalic vein at the right ventricular apex. Prior to the ICD generator
exchange, which took place 70 months after the initial implantation, all routine device interrogations
revealed normal electrical lead parameters, and cine-ﬂuoroscopy of the lead showed normal appearance
without any apparent fracture. We attempted to conduct high-voltage shock testing, as there was
concern about the possibility of silent lead malfunction. Following delivery of the ﬁrst high-voltage
shock, the device declared “possibility of output circuit damage.” Subsequent shocks could not be
delivered. Nonetheless, other lead parameters remained stable, and high-voltage lead impedance was
o20Ω. The following day, the failed generator was replaced with a new ICD generator and connected
with a new ICD lead. We then tested the new device by inducing ventricular ﬁbrillation, which was
deﬁbrillated successfully. Although electric screening in asymptomatic patients with the Riata ICD lead
remains controversial, it should be remembered that there are patients with or without detected cable
externalization in whom only high-voltage shock testing can disclose lead malfunction. Issues with Riata
leads have not yet been elucidated in full detail.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Failure of an implantable cardioverter deﬁbrillator (ICD) to deliver
therapy for sustained ventricular tachycardia (VT) or ventricular
ﬁbrillation (VF) can result in fatality. Recently, there has been great
concern over Riata lead insulation breaches. There have been reports
of insulation breaches with or without externalization of conductors in
the Riata family of leads [1–7]. There is also considerable debate about
how to manage patients with an electrically silent Riata lead mal-
function with or without a ﬂuoroscopically detected insulation breach.
We report a case of an apparently normal ICD lead that failed to
deliver shock during high-voltage shock testing.
2. Case report
An 81-year-old manwith ischemic cardiomyopathy underwent ICD
implantation for primary prevention in February 2007. The patient had
never experienced spontaneous VF. A Riata™ 1570 dual-coiled lead
(St. Jude Medical, Sylmar, CA) was passed through the left cephalic
vein and connected to an Atlas™+ DR ICD (St. Jude Medical, Sylmar,
CA). High-voltage lead impedance was 44Ω when a 5-Joule shock
was inappropriately delivered due to sinus tachycardia 55 months
earlier. Electrical lead parameters did not change before and after
shock delivery. Over the preceding 10 months, all in-clinic routine
device interrogations showed normal and stable sensing amplitudes
(range 8.7–9.4 mV), pacing lead impedances (range 335–370Ω), and
capture thresholds (range 1.25–1.5 V/1.0 ms) (Fig. 1). Because this
generator model did not allow for pain-free lead integrity testing,
we did not examine high-voltage lead impedance except through the
earlier inappropriately delivered shock. At 70 months post-implant
follow-up, the patient was scheduled for ICD generator replacement
because of battery depletion. Cine-ﬂuoroscopy of the entire length of
the lead conducted prior to exchanging the generator showed normal
appearance without any apparent separation (Fig. 2). In order to detect
possible lead-to-can abrasion, we manipulated the pocket during lead
measurement, but found normal electrical lead parameters.
We have been aware that deﬁbrillation threshold (DFT) testing
in this situation has been controversial [1,8]. However, as we were
concerned about the possibility of lead malfunction despite an
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unremarkable interrogation showing a sensing amplitude of
8.7 mV, pacing lead impedance of 335Ω, and a capture threshold
of 1.5 V/1.0 ms, we attempted to deliver a 36-Joule test shock.
The shock was delivered on the patient's intrinsic R-wave without
inducing VF to see if it would unmask a potential insulation defect.
After the ﬁrst delivery, the device declared “possible output circuit
damage.” Subsequent shock could not be delivered owing to a fault
in the pulse generator or lead. High-voltage lead impedance was
consistently below 20Ω, suggesting post-shock development of
high-voltage cable abrasion. On the following day, the patient
Fig. 1. Serial electrical lead parameters are shown (upper, R-wave amplitude; middle, pacing lead impedance; bottom, capture threshold). All routine device interrogations in
the outpatient clinic had been within normal range, with sensing amplitude 8.7–9.4 mV, pacing lead impedance 335–370 Ω, and capture threshold 1.25–1.5 V/1.0 ms over the
preceding 10 months. After shock testing, intra-cardiac R-wave amplitudes abruptly decreased despite stable pacing impedance and capture threshold.
Fig. 2. Cine-ﬂuoroscopy showed no ﬂuoroscopic evidence of cable extrusion between
the proximal and distal coils, as with other portions of the lead.
Fig. 3. No charring was apparent in the pocket area.
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showed a signiﬁcant decrease in R-wave amplitude (from 8.7 mV
to 6.1 mV) despite a stable pacing impedance of 330Ω and pacing
threshold of 1.25 V/1.0 ms (Fig. 1). In addition, no noise was
recorded on the intra-cardiac monitor. A ProtectasXT DR ICD
(Medtronic, Minneapolis, MN) was implanted and once again
positioned within the subcutaneous pocket. No charring was
apparent in the pocket area (Fig. 3). A new Sprint Quattro secure™
(Medtronic, Minneapolis, MN), bipolar, active-ﬁxation deﬁbrillator
lead was implanted through the left subclavian vein and con-
nected to the new generator. The old St. Jude Riata 1570 lead was
not extracted, but the proximal portion of the lead was cut off and
capped. On visual inspection, the extracted ICD can and cut-off ICD
lead showed no charring. In addition, there was no obvious
external abrasion at the proximal portion of the lead (Fig. 4). The
device and lead were sent to the manufacturer for analysis, which
yielded no additional information. After VF induction for DFT
testing of the new device and lead, a 15-Joule shock resulted in
successful deﬁbrillation. High-voltage lead impedance was 41Ω.
3. Discussion
This case demonstrates a potentially fatal inhibition of therapy
because of the insulation breach. Electrical dysfunction of low-voltage
circuitry can lead to oversensing with inappropriate shock and loss of
capture, whereas damaged high-voltage circuitry can lead to short-
circuiting with failure to deﬁbrillate. Electrical shorts are particularly
lethal because they may occur abruptly during shock delivery, and
thus failure to deﬁbrillate may be the ﬁrst and only sign of lead failure.
Although numerous reports of a high incidence of insulation defects in
Riata leads have been published [1–7], ours is a report of Riata lead
failure with no abnormalities on interrogation and with no ﬂuoro-
scopic evidence of insulation breach.
Leong et al. reported a similar case of a short circuit in the Riata
1570 deﬁbrillator lead, which manifested as unsuccessful deﬁbrilla-
tion [10]. In this case, product analysis of generator indicated
structural device damage owing to a short circuit in the deﬁbrillation
lead. Marenco et al. also reported an ICD system that failed to deliver
additional shock therapy after a single 25-Joule shock. In this case, a
high-voltage lead impedance alert was detected by interrogation and
lead impedance was declared out of range with possible output
circuit damage [11]. Lakshmanadoss et al. presented two cases of
failure of shock delivery in spite of apparently normal ICD leads and
ﬂuoroscopic appearance [12]. In the case reported here, we did not
perform the high-voltage lead impedance examination, which was
conducted after the patient received an inappropriate shock 55
months earlier. Furthermore, the older generation St. Jude ICD (Atlas)
being exchanged in our case did not have out of clinic high-voltage
lead impedance daily measurement capabilities. Therefore, we could
not determine whether the circuitry was damaged at the time of the
earlier inappropriate shock therapy or at the time of shock delivery
testing undertaken by our group. We are unable to explain the
precise reason for the observed lead failure, as additional information
has not yet been provided by the manufacturer. According to Hauser
et al., Riata lead failure deaths were generally caused by short circuits
between high-voltage components [13]. Short-circuiting between
the systems is also likely in our case.
This case has raised important clinical issues. First, it draws
attention to a potential ﬂaw in Riata leads with undetected
externalization. Some published reports show a high prevalence
of insulation failure with externalized cables. Parvathaneni et al.
reported that 9 of 29 leads (31%) that showed externalized
conductors had electrical abnormalities, including high-voltage
circuit shorts [6]. Theuns et al. also documented that 16 of 147
leads (11%) with lead excursion had abnormal electrical parameters
compared to 3.5% of those without lead excursion [4]. On the other
hand, Cronin et al. suggested that ﬂuoroscopy may lack the
sensitivity to detect inside-out insulation failure and externalized
conductors [14]. Previous reports have suggested that leads with
cable extrusion might not necessarily manifest overt electrical
dysfunction [1,9]. Our case also highlights the role of high-voltage
shock testing, including DFT testing, particularly at the time of
generator change. The role of routine DFT testing in clinical practice
has been recently questioned [1,8,15], because it is associated with a
mortality rate of 0.1–0.2% [16]. However, the discussion of the utility
of DFT testing in these cases is related to the need to determine the
actual DFT or to conduct a demonstration on an adequate safety
margin. The potential need to screen for HV cable dysfunction is
completely different. In the case presented here, the lead failure
would not have been recognized without high-voltage shock
testing. Shock testing for identifying an unprotected individual
may thus be required and even critical at the time of elective
generator change. The role of shock testing should be clariﬁed by
additional conﬁrmatory data and further research will be required
to justify screening for HV cable dysfunction. For the time being, we
propose that commanded high-voltage synchronized shock could
be utilized for testing system integrity without the risk of VF
induction. However, the risks and beneﬁts of this approach need
to be given adequate consideration in determining whether such a
screening test should be performed. Finally, this patient showed a
pronounced decrease in R-wave amplitude after shock testing,
when lead fracture had already been manifested. Similar R-wave
amplitude attenuations have been reported before [5,7]. Although it
is uncertain whether the attenuation of R-wave amplitude is a
reﬂection of latent lead insulation defects in Riata leads, this may be
a marker of lead fracture. Currently, it is unknown how to manage
patients with a Riata lead, with or without externalized conductors
in the absence of abnormal electrical parameters. Although electric
screening of these asymptomatic patients remains controversial,
the complete abandonment of high-voltage shock testing needs to
be cautioned against.
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